logo

CELU

Celularity·NASDAQ
--
--(--)
--
--(--)
3.67 / 10
Netural

Analyst coverage is limited to one Strong Buy, but its historical win rate is 0% and average return –23.4%, indicating low reliability. Fund‑flow score is 7.34/10, with small and medium investors net inflowing despite overall negative trends. Liquidity remains decent.

FundamentalSentiment(3.67)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-09-09
InstitutionWBB Securities
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for CELU?
  • CELU holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.67/10 (Netural).